S103: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE PKR ACTIVATOR ETAVOPIVAT (FT-4202) IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE. (31st January 2022)

Record Type:
Journal Article
Title:
S103: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE PKR ACTIVATOR ETAVOPIVAT (FT-4202) IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE. (31st January 2022)
Main Title:
S103: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE PKR ACTIVATOR ETAVOPIVAT (FT-4202) IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE
Authors:
Lal, A.
Brown, C.
Coates, T.
Kalfa, T.
Kwiatkowski, J.L.
Brevard, J.
Trenor, C.
Wood, K.
Sheth, S.
Abstract:
Is Part Of:
HemaSphere. Volume 6(2022)Supplement 1
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 1
Issue Display:
Volume 6, Issue 1 (2022)
Year:
2022
Volume:
6
Issue:
1
Issue Sort Value:
2022-0006-0001-0000
Page Start:
2
Page End:
2
Publication Date:
2022-01-31
Subjects:
Hematology -- Periodicals
616.15005
Journal URLs:
https://journals.lww.com/hemasphere/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:
10.1097/01.HS9.0000821380.12178.0d ↗
Languages:
English
ISSNs:
2572-9241
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
21179.xml